Transfection of TAP 1 gene restores HLA class I expression in human small-cell lung carcinoma

International Journal of Cancer

Volumn 75, Issue 1, 1998, Pages 112-116

  Singal, Dharam P ^a   Ye, Ming ^a   Bienzle, Dorothea ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1;

ANTIGEN EXPRESSION; ARTICLE; CANCER IMMUNOTHERAPY; GENE TARGETING; GENE THERAPY; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; LUNG SMALL CELL CANCER; METASTASIS INHIBITION; PRIORITY JOURNAL; TUMOR REJECTION;

ANTIGENS, NEOPLASM; ATP-BINDING CASSETTE TRANSPORTERS; CELL MEMBRANE; EXTRACELLULAR MATRIX PROTEINS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; LUNG NEOPLASMS; NERVE TISSUE PROTEINS; TRANSFECTION; TUMOR CELLS, CULTURED; VIRAL MATRIX PROTEINS;

EID: 0032484555     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980105)75:1<112::AID-IJC17>3.0.CO;2-I     Document Type: Article

References (20)

1. ARNOLD, D., DRISCOLL, J., ANDROLEWICZ., M., HUGHES, E., CRESSWILL, P. and SPIES, T., Proteasome subunits encoded in the MHC arc not generally required for the processing of peptides bound hy MHC class I molecules. Nature (Lond.), 360, 171-1741 (1992).
2. BROWN, M.G., DRISCOU., J. and MONACO, J.J., MHC-linked low-molecular mass polypeptide subunits define distinct subsets of protuasomes, Implications for divergent function among distinct protcasomc subsets. J. Immuol., 151, 1193-1204 (1993).
3. CARLOW, D.A., KERBEL, R.S. and ELLIOTT, H.H., Failure of expression of class I major histocompatibility antigens to alter tumor immunogenicity of a spontaneous murine carcinoma. J. nat. Cancer Inst., 81, 759-767 (1989).
4. CROMME., F.V., AIREY, J., HEEMELS, M.T., PLOEGH, M., KEATING, P.J., STERN, P.L., MEIJER, C.J.L.M. and WALBOOMERS, J.M.M., Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas. J. exp. Med., 179, 335-340 (1994).
5. FEHLING, H.J., SWAT, W., LAPLACE, C., KUHN, R., RAJEWSKY, K., MULLER, U. and VON BOEHMER, H., MHC class 1 expression in mice lacking the protcasome subunit LMP-7. Science. 265, 1234-1237 (1994).
6. GARRIDO, K. CADRERA, T., LOPEZ-NEVOT, M.A. and RUIZ-CABELLO, E., HLA class I antigens in human tumors. Adv. Cancer Res., 67, 155-194 (1995).
7. HUI, K., GROSVALD, F. and FESTENSTEIN, H., Rejection of transplantable AKR leukaemia cells following MHC DNA-mediated cell transformation, Nature (Lond.), 311, 750-752 (1984).
8. KAKLAMANIS, L., TOWNSEND, A., DOUSSIS-ANAGNOSTOPOULOU., L.A., MORTKNSKN, N., HARRIS, A.L. and GATTER, K.C., Loss of major histocompatibility complex-encoded transporter associated with antigen presentation (TAP) in colorectal cancer. Amer. J. Pathol., 145, 505-509 (1994).
9. MOMBURG, F., DEGNERR, T., BACCHUS, E., MOLDENHAUER, G., HAMMERLING, G.J. and MÖLLER, P., Loss of HLA-A.B.C and de nova expression of HLA-D in colorectal cancer. Int. J. Cancer. 37, 179-184 (1986).
10. MOMBURG, F., ORTIZ-NAVARREKE, V., NEELVES, J., GOULMAY, K., VAN DE WAL, Y., SPITS, H., POWIS, S.J., BUTCHER, G.S., HOWARD, J.C., WALDEN, P. and HAMMMRLING, G., Proteasome subunits encoded by the major histocompatibility complex are not essential for antigen presentation, Nature (Lond.), 360, 174-177 (1992).
11. RESTIFO, N.P., ESQUIVEL, E., KAWAKAMI, Y., YEWDELL., J.W., MUIE, J.J., ROSENBERG, S.A. and BENINK, J.R., Identification of human cancers deficient in antigen processing. J. exp. Med., 177, 265-272 (1993).
12. ROTEM-YEHNDAR, R., GROETTRUP, M., SOZA, M., KLOETZEL, P.M. and EHRIICH, R., LMP-associaied protcolytiC activities and TAP-dEpendent peptide transport for class I MHC molecules arc suppressed in cell lines transformed by the highly oncogcnic. adenovirus 12. J. exp. Med., 183, 499-514 (1996).
13. SIBHILLE, C., GOVLD, K.G., WILLARD-GALLO, K., THOMSON, S., RIVETT, A.J., POWIS, S., BUTHCHER, G.W. and DE BAETSELIER, P., LMP2 proteasomes are required for the presentation of specitic antigens to eylotoxic T lymphocytes. Curr. Biol., 5, 923-930 (1995).
14. SINGAL, D.P., YE, M. and QUADRI, S.A., Major histocompatibility-cncoded human proteasnme LMP2: Oencomic organization and a new form of mRNA. J. biol. Chem., 270, 1966-1970 (1995).
15. SINGAL, D.P., YE, M., Ni, J. and SNIDER, D.P., Markedly decreased expression of TAP1 and LMP2 genes in HLA class I-delicient human tumor cell lines. Immunol. Lett., 50, 149-154 (1996a).
16. SINGAL, D.P., YE. M, and QIU, X., Molecular basis for lack of III.A class I antigens in human small-cell lung carcinoma cell lines. Int. J. Cancer, 68, 629-636 (1996b).
17. TANAKA, K., ISSELBACHER, K.J., KHOURY, G. and JAY, C., Reversal of oicogenesis by the expression of a major histocompatibiliiy complex class I gene. Science, 228, 26-30 (1985).
18. VAN KAER, L., ASHTON-RlCKARIJT, P.G., EICHELBERGER, M., CACZYNSKA, M., NAGASHIMA, K., ROCK, K.I., COLDBERG, A.L., DOMETRY, P.C. and TONEGAWA, S., Altered peptidase and viral-specific T cell response in LMP2 mutant mice. Immunity, 1, 533-541 (1994).
19. WALLICH, R., BULBUC, N., HAMMERLING, G.J., KATZAV, S., SMHOAI, S. and FELDMAN, M., Abrogation of metastatic properties of tumour cells by de novo expression of H-2K antigens following H-2 gene transfcction. Nature (Lond.), 315, 301-305 (1985).
20. YEWDELL, J., LAPHAM, C., BACIK, I., SPIES, T. and BENNIK, J., MHC-encoded proteasome subunils LMP2 and LMP7 are not required for efficient antigen presentation. J. Immunol., 152, 1163-1170 (1994).